Digestive & Intestinal Remedies (Pharmacies) - Ukraine

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$275.40m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.70%, resulting in a market volume of US$330.10m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$7.26 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Ukraine is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Ukraine are shifting towards more natural and organic remedies. Consumers are becoming increasingly health-conscious and are seeking products that are perceived to be more natural and have fewer side effects. This has led to a growing demand for herbal and plant-based remedies in the market. Additionally, customers are also looking for products that are convenient and easy to use, such as tablets or capsules that can be taken on-the-go. Trends in the Digestive & Intestinal Remedies (Pharmacies) market in Ukraine are being influenced by global and regional market trends. One of the key trends is the increasing prevalence of digestive and intestinal disorders, such as irritable bowel syndrome and acid reflux, which is driving the demand for remedies in the market. Additionally, there is a growing awareness and acceptance of alternative medicine practices, such as traditional Chinese medicine and Ayurveda, which offer holistic approaches to digestive health. This is leading to the introduction of new products in the market that cater to these alternative medicine practices. Local special circumstances in Ukraine are also contributing to the development of the Digestive & Intestinal Remedies (Pharmacies) market. The country has a large aging population, which is more prone to digestive and intestinal disorders. This demographic trend is driving the demand for remedies in the market. Furthermore, Ukraine has a well-established pharmaceutical industry, which allows for the development and production of a wide range of digestive and intestinal remedies. This local expertise and infrastructure are supporting the growth of the market. Underlying macroeconomic factors are also playing a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Ukraine. The country has been experiencing economic growth in recent years, which has led to an increase in disposable income levels. This has allowed consumers to spend more on healthcare products, including digestive and intestinal remedies. Additionally, the government has been investing in healthcare infrastructure and promoting the use of generic medicines, which has made remedies more accessible and affordable for the population. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in Ukraine is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as consumers become more health-conscious and seek natural and convenient remedies for digestive and intestinal disorders.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.